Evoke Pharma
EVOK
EVOK
19 hedge funds and large institutions have $7.91M invested in Evoke Pharma in 2018 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
Holders
19
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$47K | |
| 2 | +$28.9K | |
| 3 | +$10.7K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$8.58K |
Top Sellers
| 1 | -$111K | |
| 2 | -$82K | |
| 3 | -$80K | |
| 4 |
TSS
Two Sigma Securities
New York
|
-$55K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$9.46K |